SureTrader
Home > Boards > US Listed > Biotechs > NorthWest Biotherapeutics (NWBO)

Here is the link to Germany DCVax Clinical

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
john1045 Member Profile
 
Followed By 28
Posts 1,985
Boards Moderated 0
Alias Born 06/09/11
160x600 placeholder
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 1/27/2016 5:02:18 PM
NW Bio Announces Appointment Of Two New Independent Directors With Biotech/Pharma Expertise and Cybersecurity/Investigations ... "PR Newswire (US)" - 1/25/2016 9:30:00 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) "Edgar (US Regulatory)" - 1/12/2016 5:07:45 PM
NW Bio Issues Statement on Adverse Market Conditions And NW Bio Stock Decline "PR Newswire (US)" - 1/8/2016 9:15:00 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) "Edgar (US Regulatory)" - 12/30/2015 5:28:32 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 12/29/2015 5:25:22 PM
NW Bio Announces Closing Of Registered Direct Offering of $12.6 Million "PR Newswire (US)" - 12/24/2015 4:29:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 12/24/2015 12:23:22 PM
NW BIO ANNOUNCES A REGISTERED DIRECT OFFERING OF $12.6 MILLION "PR Newswire (US)" - 12/23/2015 9:00:00 AM
Notice of Effectiveness (effect) "Edgar (US Regulatory)" - 12/23/2015 6:01:43 AM
Robbins Arroyo LLP: Northwest Biotherapeutics, Inc. (NWBO) Misled Shareholders According to a Recently Filed Class Action "Business Wire" - 12/21/2015 4:07:00 PM
NW Bio Announces Annual Meeting Results, Re-Election of Directors "PR Newswire (US)" - 12/21/2015 1:05:00 PM
Securities Registration Statement (simplified Form) (s-3/a) "Edgar (US Regulatory)" - 12/14/2015 5:17:16 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 12/14/2015 3:09:19 PM
NW Bio Announces Establishment of Special Committee And Law Firm To Conduct Independent Investigation of Recent Allegations "PR Newswire (US)" - 12/8/2015 8:15:00 AM
NW Bio Statement Regarding Appointments "PR Newswire (US)" - 12/8/2015 8:15:00 AM
NW Bio Announces Establishment of Special Committee And Law Firm To Conduct Independent Investigation of Recent Allegations "PR Newswire (US)" - 12/8/2015 2:30:00 AM
NW Bio Statement Regarding Appointments "PR Newswire (US)" - 12/8/2015 2:30:00 AM
NW Bio Plans to Expand Board, Welcomes Woodford's Call For Independent Investigation Of Allegations In Anonymous Internet Rep... "PR Newswire (US)" - 11/30/2015 7:15:00 AM
Amended Statement of Beneficial Ownership (sc 13d/a) "Edgar (US Regulatory)" - 11/24/2015 5:20:52 PM
Glancy, Prongay & Murray LLP Commences Investigation on Behalf of Northwest Biotherapeutics, Inc. Investors "Business Wire" - 11/23/2015 8:59:00 PM
3 Stocks I Would Avoid at All Costs "The Motley Fool" - 11/16/2015 7:01:05 PM
Initial Statement of Beneficial Ownership (3) "Edgar (US Regulatory)" - 11/16/2015 6:48:47 PM
Securities Registration Statement (simplified Form) (s-3) "Edgar (US Regulatory)" - 11/13/2015 6:04:39 AM
Feature Analyst Alert and 4 Brief Updates "InvestorsHub NewsWire" - 11/10/2015 8:00:00 AM
john1045   Monday, 12/24/12 04:47:16 PM
Re: None
Post # of 53199 
Here is the link to Germany DCVax Clinical trials with an area I pasted from long report so they obviously are recruiting over there as of now....

http://translate.google.com/translate?hl=en&sl=de&u=http://www.uniklinik-duesseldorf.de/fileadmin/Datenpool/einrichtungen/universitaetstumorzentrum_id505/neu2012/Dateien/Klinische_Studien_UTZ_Duesseldorf.pdf&prev=/search%3Fq%3Ddcvax%26start%3D50%26hl%3Den%26sa%3DN%26tbo%3Dd%26biw%3D1366%26bih%3D586%26tbs%3Dqdr:w&sa=X&ei=I8nYULiqM7GH0QGx6oDACg&ved=0CGwQ7gEwCTgy

Page 11 of 23

Clinical trials in brain tumors


IND No. 10206

Glioblastoma (brain cancer)

Phase II clinical trial to evaluate DCVax-Brain, autologous dendritic cells pulsed with tumor lysate, for treatment

of glioblastoma multiforme.



A Phase II Clinical Trial Evaluating DCVax-Brain, Autologous Dendritic Cells Pulsed with Tumor Lysate for the Treatment of Glioblastoma

Multiforme

Your contact:

Prof. Dr. Michael Sabel

Michael.Sabel @ med.uni-duesseldorf.de



Page 12


Current clinical studies at University Cancer Center UTZ

University Cancer Center UTZ

Info Phone: 0211-8108200

at the University Hospital Dusseldorf

www.uniklinik-duesseldorf.de/utz

Stand: 01/2013

Page 12 of 23

Clinical trials in brain tumors

Fraunhofer Institute

Glioblastoma (brain cancer)

Phase II clinical study evaluating DCVax ®-L Brain autologous dendritic cells loaded with tumor lysate antigen for

Treatment of glioblastoma multiforme (GBM)

Clinical phase II trial to evaluate DCVax ®-L Brain autologous dendritic cells loaded with tumor lysate antigen for treatment of glioblastoma

multiforme (GBM)

Your contact:

Infoline

Tel: 0211-8108200

uta@med.uni-duesseldorf.de


SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist